M.D. Anderson Cancer Center赞助的临床试验
总计3800个结果
-
M.D. Anderson Cancer CenterApexigen America, Inc.; Pyxis Oncology主动,不招人
-
The Methodist Hospital Research InstituteM.D. Anderson Cancer Center终止
-
Light Chain Bioscience - Novimmune SAM.D. Anderson Cancer Center完全的
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology Company终止
-
M.D. Anderson Cancer CenterUnited States Department of Defense完全的
-
M.D. Anderson Cancer CenterUnited States Department of Defense撤销
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; OSI Pharmaceuticals完全的
-
M.D. Anderson Cancer CenterUnited States Department of Defense完全的
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; BTG International Inc.撤销
-
M.D. Anderson Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.完全的
-
M.D. Anderson Cancer CenterUnited States Department of Defense终止
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)完全的
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)撤销
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Stanford University; Rockefeller University主动,不招人
-
University of ZurichM.D. Anderson Cancer Center; The Netherlands Cancer Institute招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Spectrum Pharmaceuticals, Inc主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ortho Biotech, Inc.完全的
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics Inc完全的
-
M.D. Anderson Cancer CenterThe Blanton Davis Ovarian Cancer Research Program未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Sprint for Life完全的卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢未分化癌 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 输卵管未分化癌 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | II 期输卵管癌 AJCC v6 和 v7 | II 期卵巢癌 AJCC v6 和 v7 | IIA 期输卵管癌 AJCC v6 和 v7 | IIA 期卵巢癌 AJCC V6 和 v7 | IIB 期输卵管癌 AJCC v6 和 v7 | IIB 期卵巢癌 AJCC v6 和 v7 | IIC 期输卵管癌 AJCC v6 和 v7 | IIC 期卵巢癌 AJCC v6 和 v7 | III 期输卵管癌 AJCC v7 | III 期卵巢癌 AJCC... 及其他条件美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); University of Texas完全的
-
M.D. Anderson Cancer CenterLynne Cohen Foundation for Ovarian Cancer Research完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Trevarx Biomedical, Inc招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.招聘中慢性期慢性粒细胞白血病 | 费城染色体阳性 | BCR-ABL1 阳性慢性粒细胞白血病 | BCR-ABL1 阳性美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.主动,不招人恶性实体肿瘤 | 软组织肉瘤 | 复发性卵巢癌 | 三阴性乳腺癌 | 复发性骨肉瘤 | 难治性骨肉瘤 | 骨肉瘤 | 骨巨细胞瘤 | 卵巢癌肉瘤 | 铂类耐药卵巢癌 | 去分化软骨肉瘤 | 骨巨细胞瘤的恶性程度 | 低分化甲状腺癌 | 甲状腺间变性癌 | 甲状腺鳞状细胞癌 | 未分化高级别多形性骨肉瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Massachusetts General Hospital主动,不招人
-
Massachusetts General HospitalM.D. Anderson Cancer Center; National Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Massachusetts General Hospital完全的
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI)完全的
-
Instituto Nacional de Saúde, MozambiqueM.D. Anderson Cancer Center尚未招聘
-
Pack HealthBristol-Myers Squibb; M.D. Anderson Cancer Center招聘中
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; AstraZeneca主动,不招人
-
M.D. Anderson Cancer CenterInnovent Biologics (Suzhou) Co. Ltd.主动,不招人
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Celgene主动,不招人
-
Clinigen, Inc.Johns Hopkins University; M.D. Anderson Cancer Center终止
-
M.D. Anderson Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.完全的
-
M.D. Anderson Cancer CenterUnited States Department of Defense完全的
-
M.D. Anderson Cancer CenterUnited States Department of Defense完全的
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)完全的
-
M.D. Anderson Cancer CenterBayer; Celgene; Onyx Therapeutics, Inc.完全的
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)撤销
-
M.D. Anderson Cancer CenterSchering-Plough; Enzon Pharmaceuticals, Inc.终止